QVT Financial LP - Significant Ownership

Signature - Title
/s/ Meg Eisner - Authorized Signatory
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by QVT Financial LP.

Email me when QVT Financial LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of QVT Financial LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALLT Allot Ltd. Ordinary Shares, par value ILS 0.10 per share 10.45% $47.7M $14.2M 5.06M +42.4% QVT Financial LP Nov 18, 2025
WHWK Aadi Bioscience, Inc. Common stock, $0.0001 par value per share 9.37% $3.56M 2.31M QVT Financial LP Dec 31, 2024
TRML Tourmaline Bio, Inc. Common Stock, $0.0001 par value per share 8.39% $34.9M $11M 2.15M +46.2% QVT Financial LP Jun 30, 2025
ROIV Roivant Sciences Ltd. Common shares, par value $0.0000000341740141 per share 4.3% $319M -$395M 29.4M -55.3% QVT Financial LP Jun 30, 2025

Schedules 13D/G Reported by QVT Financial LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.